These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 475976)

  • 21. [Liver storages induced by perhexiline maleate : histological, histo-enzymological, biochemical date (author's transl)].
    Lageron A
    Therapie; 1981; 36(3):289-91. PubMed ID: 7292406
    [No Abstract]   [Full Text] [Related]  

  • 22. [Mechanism of action, complications, pharmacokinetics and precautions in the use of perhexiline maleate].
    Dudognon P; Beaugrand M; Singlas E; Benaïm R; Uzan C; Meyrier A
    Coeur Med Interne; 1979; 18(1):129-38. PubMed ID: 477264
    [No Abstract]   [Full Text] [Related]  

  • 23. [Acute hepatic failure due to perhexiline maleate].
    Roche J; Fournet J; Meullenet J; Faure H; Massot C
    Nouv Presse Med; 1979 Feb; 8(7):521-2. PubMed ID: 461164
    [No Abstract]   [Full Text] [Related]  

  • 24. [Complications after perhexiline maleate and amiodarone chlorhydrate treatment in a same patient: hypoglycemia, polyneuritis and hyperthyroidism (author's transl)].
    Krulik M; Kaloustian E; Audebert AA; Debray J
    Sem Hop; 1980 Feb 18-25; 56(7-8):315-8. PubMed ID: 6246624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hepatitis caused by perhexiline maleate].
    Lenoir C; Blanchon P
    Coeur Med Interne; 1978; 17(1):69-75. PubMed ID: 346302
    [No Abstract]   [Full Text] [Related]  

  • 26. Hepatotoxicity following treatment with perhexiline maleate.
    Long JP; Fitzgerald O; Maurer BJ
    Ir Med J; 1980 Jul; 73(7):275-6. PubMed ID: 7440121
    [No Abstract]   [Full Text] [Related]  

  • 27. [Letter: Subacute toxic hepatitis following perhexiline maleate therapy].
    Pelletier M; Lambert R; Paliard P; Bory R
    Nouv Presse Med; 1976 Apr; 5(16):1070. PubMed ID: 1272785
    [No Abstract]   [Full Text] [Related]  

  • 28. Morphological changes in CNS of rats treated with perhexiline maleate (pexid).
    Jung HJ; Suzuki K
    Acta Neuropathol; 1978 Jun; 42(3):159-64. PubMed ID: 209656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The action of perhexiline maleate in patients with angina and its effect on liver function.
    Rees JR
    Arq Bras Cardiol; 1973 Aug; 26 Suppl 1():108-12. PubMed ID: 4595479
    [No Abstract]   [Full Text] [Related]  

  • 30. Impaired oxidation of debrisoquine in patients with perhexiline liver injury.
    Morgan MY; Reshef R; Shah RR; Oates NS; Smith RL; Sherlock S
    Gut; 1984 Oct; 25(10):1057-64. PubMed ID: 6479680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diffuse polymorphous inclusions in a patient treated with perhexiline maleate (author's transl)].
    Hauw JJ; Singer B; Poupon R; Lecomte D; de Saint-Maur PP; Lageron A; Pollet S
    Nouv Presse Med; 1978 Mar; 7(10):817-20. PubMed ID: 205835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of perhexiline maleate on lipid metabolism in the rat. III. Liver gangliosides after administration of high doses of perhexiline maleate.
    Hoenig V; Werner F
    Pharmacol Res Commun; 1980 Jan; 12(1):29-33. PubMed ID: 7384161
    [No Abstract]   [Full Text] [Related]  

  • 33. Enantioselectivity in the tissue distribution of perhexiline contributes to different effects on hepatic histology and peripheral neural function in rats.
    Licari G; Milne RW; Somogyi AA; Sallustio BC
    Pharmacol Res Perspect; 2018 Jun; 6(3):e00406. PubMed ID: 29864243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The anti-arrhythmic effects of perhexiline maleate in patients with ischaemic heart disease.
    Gitlin N
    S Afr Med J; 1975 Nov; 49(51):2115-7. PubMed ID: 54942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of perhexiline maleate on lipid metabolism in the rat. II. Liver and lung phospholipids after administration of high doses of perhexiline maleate.
    Hoenig V; Werner F
    Pharmacol Res Commun; 1979 Jun; 11(6):509-15. PubMed ID: 504325
    [No Abstract]   [Full Text] [Related]  

  • 36. Liver disease induced by perhexiline maleate.
    Horowitz JD; White HD; Goble AJ
    Med J Aust; 1982 Jul; 2(1):9-10. PubMed ID: 7110022
    [No Abstract]   [Full Text] [Related]  

  • 37. Perhexiline maleate toxicity on human liver cell lines.
    Le Gall JY; Guillouzo A; Glaise D; Deugnier Y; Messner M; Bourel M
    Gut; 1980 Nov; 21(11):977-84. PubMed ID: 7192674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Muscle and nerve changes induced by perhexiline maleate in man and mice.
    Fardeau M; Tomé FM; Simon P
    Muscle Nerve; 1979; 2(1):24-36. PubMed ID: 232538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by perhexiline maleate.
    Ramu A; Fuks Z; Gatt S; Glaubiger D
    Cancer Res; 1984 Jan; 44(1):144-8. PubMed ID: 6690032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in the lysosomes and mitochondria isolated from the liver, kidney and heart of rats treated with perhexiline maleate.
    Bendirdjian JP; Viotte G; Bichara M; Foucher B; Fillastre JP
    Toxicol Eur Res; 1982 Nov; 4(6):297-300. PubMed ID: 7170723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.